Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Gross Profit: 2021-2025

Historic Gross Profit for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to $93.5 million.

  • Krystal Biotech's Gross Profit rose 21.23% to $93.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $351.8 million, marking a year-over-year increase of 57.31%. This contributed to the annual value of $270.5 million for FY2024, which is 468.11% up from last year.
  • Krystal Biotech's Gross Profit amounted to $93.5 million in Q3 2025, which was up 5.24% from $88.9 million recorded in Q2 2025.
  • Krystal Biotech's Gross Profit's 5-year high stood at $93.5 million during Q3 2025, with a 5-year trough of -$1.5 million in Q1 2021.
  • Its 3-year average for Gross Profit is $64.9 million, with a median of $77.2 million in 2024.
  • Data for Krystal Biotech's Gross Profit shows a peak YoY soared of 825.92% (in 2024) over the last 5 years.
  • Over the past 4 years, Krystal Biotech's Gross Profit (Quarterly) stood at -$1.5 million in 2021, then reached $39.3 million in 2023, then soared by 119.40% to $86.2 million in 2024, then climbed by 21.23% to $93.5 million in 2025.
  • Its Gross Profit was $93.5 million in Q3 2025, compared to $88.9 million in Q2 2025 and $83.2 million in Q1 2025.